Xryma Plc's Strategic Move for Euronext Paris Listing
In a recent announcement, Xryma Plc, a Cyprus-based corporation, revealed its intent to reapply for listing on the Euronext Paris within the next 12 months. This significant step is contingent upon receiving the necessary approvals from Euronext and other regulatory authorities. To enhance the upcoming listing, Xryma plans to implement a pre-listing liquidity facility and a price discovery process designed to benefit both existing and prospective shareholders.
Understanding the Liquidity Facility and Price Discovery Process
The proposed liquidity facility aims at providing shareholders with an opportunity to divest their stocks before the company officially lists on Euronext. This initiative includes:
- - Private Placement: Aimed at institutional and qualified investors.
- - Secondary Market Offerings: Existing shareholders can sell portions of their holdings if they seek to exit before the listing.
The prerequisites for the Euronext listing may necessitate regulatory approval, making it crucial for Xryma to establish a clear strategy ahead.
According to CEO John Karantzis, the decision to pursue this process is largely informed by feedback from shareholders, who expressed a desire for a straightforward method to liquidate their investments. The company is structuring the placement not only to meet this demand but also to ensure a credible reference price for its shares through a bookbuilding process involving institutional investors.
Benefits for Shareholders
The liquidity facility will empower shareholders by offering them the chance to:
- - Exit without Hassle: Sell shares easily without needing to set up an EU brokerage account.
- - Reap Fair Value: Receive shares at the same price offered to qualified investors during the placement.
- - Participate in a Market-Driven Pricing Mechanism: Establish a reference price based on demand from institutional players, potentially facilitating a more organized trading atmosphere once the company is publicly listed.
Timeline and Next Steps
Anticipated communications about the program will be distributed to shareholders in August 2026, detailing how to participate in the liquidity facility. Shareholders will have the option to set a minimum price for their shares, ensuring they sell at a favorable rate, should market conditions allow for such a price during the bookbuilding phase.
However, it is essential for shareholders that the process remains entirely voluntary. Those opting not to sell will maintain their current holdings, and any adjustments to allocations may occur depending on demand from other investors.
Conclusion: A Forward-Looking Strategy
Xryma's proactive approach through the liquidity facility and price discovery process is designed to ensure a smooth transition to being a publicly listed company. With its commitment to addressing shareholder feedback, Xryma intends to establish an orderly market and ensure a seamless entry to the Euronext Paris exchange. The ongoing communications and final arrangements will play a pivotal role in defining how the market perceives this new phase for Xryma.
Important Disclosure
This press release may contain inside information as defined in Article 7(1) of Regulation (EU) No. 596/2014 (Market Abuse Regulation).
All interested parties are encouraged to remain informed through Xryma's official channels as new developments arise, ensuring an engaged and aware shareholder base. For detailed insights, shareholders may refer to the dedicated investor information found on
Xryma's Investor Site.